These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30825335)

  • 1. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
    Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
    Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
    Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
    J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
    Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
    Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
    Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
    Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic features with associated histological and molecular alterations in serrated polyps with dysplasia: Retrospective analysis of a tertiary case series.
    Trecca A; Borghini R; Medicina D; Del Sordo R; Mandelli G; Bella A; Galloro G; Fu KI; Villanacci V
    Dig Liver Dis; 2024 Apr; 56(4):687-694. PubMed ID: 37778895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations.
    Agaimy A; Stoehr R; Vieth M; Hartmann A
    Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
    Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
    Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
    Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
    Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas.
    Travaglino A; D'Armiento FP; Cassese G; Campanino MR; Borrelli G; Pignatiello S; Luglio G; Maione F; De Palma GD; D'Armiento M
    Histopathology; 2019 Aug; 75(2):160-173. PubMed ID: 30815911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
    Kuan SF; Navina S; Cressman KL; Pai RK
    Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
    Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
    Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
    Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
    Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of MLH1 in non-dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps.
    Yozu M; Kem M; Cenaj O; Mino-Kenudson M; Odze RD; Misdraji J
    Histopathology; 2019 Sep; 75(3):376-384. PubMed ID: 30974487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.